Platform implements patient insights and data to help create diversity action plans.
Medidata announced the launch of its Medidata diversity program, aimed to improve diversity, equity, and inclusion in clinical trials. According to the company, this program supports biopharmaceutical and medical device companies and contract research organizations (CROs) by addressing common systemic and clinical barriers that can hinder a diverse range of individuals from participating in clinical trials.
“Facilitating more diverse participation in clinical trials is a critical and complex challenge, not only for the life sciences industry but for the patients and caregivers participating in the trials,” said Anthony Costello, CEO, Patient Cloud, Medidata. “The Medidata Diversity Program, the most comprehensive solution to date, will help sponsors and CROs move from awareness about a diversity challenge to planning and solving for it as a standard and sustainable part of their clinical development programs.”
Reference: Medidata Launches Industry’s Most Comprehensive Program to Support Clinical Trials Diversity Initiatives. Medidata. September 19, 2023. Accessed September 25, 2023. https://www.medidata.com/en/about-us/news-and-press/medidata-launches-industrys-most-comprehensive-program-to-support-clinical-trials-diversity-initiatives/#:~:text=New%20York%20%E2%80%93%20September%2019%2C%202023,and%20inclusion%20in%20clinical%20trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.